Interaction of Drugs Used for the Treatment of Cardiovascular Diseases

Interaction of Drugs Used for the Treatment of Cardiovascular Diseases

Combined therapy in cardiology is currently the most recognized method of treatment, especially in patients with hypertension. Approximately in 50 % of patients with hypertension, monotherapy is effective. However to achieve the desired effect in the remaining half of patients, simultaneous administ...

Full description

Bibliographic Details
Main Authors:	Galina N. Kovalskaya, Dina Y. Zhukova, Ekaterina N. Mikhalevich
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2019-04-01
Series:	Acta Biomedica Scientifica
Subjects:	drug interaction combined therapy cardiovascular disease
Online Access:	https://www.actabiomedica.ru/jour/article/view/1976

Similar Items

Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
by: M. Jyotsna, et al.
Published: (2020-09-01)

Essentials of Herb-Drug Interactions in the Elderly With Cardiovascular Disease
by: Sulaiman Sultan, et al.
Published: (2015-11-01)

The interaction of drugs to treat cardiovascular diseases and testosterone therapy, their effects and characteristics
by: Duygun Altıntaş Aykan, et al.
Published: (2021-04-01)

Prescription Pattern and Potential Drug-Drug Interactions of Antihypertensive Drugs in a General Hospital, South Ethiopia
by: Fanta Gashe Fufa, et al.
Published: (2015-12-01)

Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
by: Marwan Sheikh-Taha, et al.
Published: (2021-04-01)

The pharmacogenetics of cardiovascular drugs
by: Stanković Sanja, et al.
Published: (2014-01-01)

Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia
by: Assefa YA, et al.
Published: (2020-01-01)

Using interspecies biological networks to guide drug therapy
by: Jacunski, Alexandra
Published: (2017)

Chronic obstructive pulmonary disease in combination with cardiovascular diseases: treatment with inhalatory cholinolytic drugs1
by: Z R Aisanov, et al.
Published: (2004-12-01)

Risk factors for potential drug-drug interactions in a general neurology ward
by: Kostić Marina J., et al.
Published: (2021-01-01)

Pathogenesis of Anti-cancer Drugs-induced Cardiovascular Diseases: The State-of-the-art
by: TAN Wenyong, et al.
Published: (2018-11-01)

Development of technological complex for production of compounded infusion admixtures in hospital pharmacies
by: E. N. Mikhalevich, et al.
Published: (2017-05-01)

Assessment of non-compliance, adverse drug reactions, and drug interactions in patients with cardiovascular diseases admitted to medical wards at Songkhla Hospital
by: J Kanjanakiritamrong, et al.
Published: (2005-08-01)

Antimalarial herbal drugs: a review of their interactions with conventional antimalarial drugs
by: Earnest Oghenesuvwe Erhirhie, et al.
Published: (2021-01-01)

Prevalence and Clinical Significance of Drug–Drug and Drug–Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece
by: Marios Spanakis, et al.
Published: (2021-02-01)

Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
by: Naim Shehadeh, et al.
Published: (2018-08-01)

Combination therapy in the treatment of hypertension
by: Alberto Francisco Rubio-Guerra
Published: (2018-06-01)

Concomitant prescription of psychotropic and cardiovascular drugs in elderly patients
by: Zeynep Ozturk, et al.
Published: (2017-10-01)

Prescribing pattern of antipsychotic drugs in the outpatient department of psychiatry in Silchar Medical College and Hospital, Assam
by: Pinaki Chakravarty, et al.
Published: (2016-01-01)

Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment
by: Marloes Zoetemelk, et al.
Published: (2020-06-01)

Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases
by: Ruth Webster, et al.
Published: (2020-08-01)

EXTEMPORANEOUS MANUFACTURING OF INTRAVENOUS ADMIXTURES IN HOSPITAL PHARMACIES OF RUSSIAN FEDERATION
by: G. N. Kovalskaya, et al.
Published: (2017-09-01)

Renin angiotensin-aldosterone system blockers: chronic kidney disease and cardiovascular risk
by: D.D. Ivanov, et al.
Published: (2018-03-01)

Optimization of Medicinal Treatment of Patients with Glaucoma in Combination with Concurrent System Pathology. Part 1: Cardiovascular Pathology
by: A. N. Zhuravleva, et al.
Published: (2020-09-01)

Blood Pressure Monitoring in Cardiovascular Disease
by: Carlos Menéndez Villalva, et al.
Published: (2017-04-01)

Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment
by: Marloes Zoetemelk, et al.
Published: (2020-11-01)

ANICHKOV study: the effect of combined hypotensive and lipid-lowering therapy on cardiovascular complications in patients of high and very high risk
by: I V Sergienko, et al.
Published: (2019-04-01)

Cardiovascular risk, metabolic disturbances, and the choice of antihypertensive therapy
by: M. N. Mamedov, et al.
Published: (2011-08-01)

Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment
by: Judy R. van Beijnum, et al.
Published: (2020-09-01)

The use of capillary electrophoresis in the simultaneous determination of fixed-dose combination drugs for cardiovascular diseases
by: Gabriel Hancu, et al.
Published: (2020-09-01)

Ranolazine: A true pluripotent cardiovascular drug or jack of all trades, master of none?
by: Alice Mezincescu, et al.
Published: (2018-04-01)

TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS
by: A. M. Shilov, et al.
Published: (2015-09-01)

RESULTS OF MONITORING OF PRESCRIPTION OF POTENTIALLY DANGEROUS COMBINATIONS OF DRUGS IN PHARMACOTHERAPY UNDER INPATIENT TREATMENT
by: Serhii Hryshchuk
Published: (2018-11-01)

What drugs do hypertension patients take in clinical practice? Structure of antihypertensive drugs in a large siberian region
by: Y. I. Grinshtein, et al.
Published: (2016-12-01)

Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions
by: Yong-Jian Geng, et al.
Published: (2021-01-01)

Use of Cardiovascular Drugs for Primary and Secondary Prevention of Cardiovascular Disease Among Rural-Dwelling Older Chinese Adults
by: Lin Cong, et al.
Published: (2020-12-01)

Evaluation of Potential Drug Interactions and Related Factors in Patients Admitted in Department of Cardiology of Farshchian Heart Hospital of Hamadan
by: Maryam Torkashvand, et al.
Published: (2018-09-01)

Impact of clinical pharmacist's interventions on potential drug–Drug interactions in the cardiac care units of two university hospitals in Shiraz, South of Iran
by: Mojtaba Shafiekhani, et al.
Published: (2019-01-01)

The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib
by: H. Jonathan G. Lindström, et al.
Published: (2020-05-01)

Treatment of patients with high cardiovascular risk: a modern view on combined therapy
by: Z N Blankova, et al.
Published: (2017-03-01)